Arizona Cancer Center; University of Arizona

Tucson, Arizona 85724-5081

0 studies enrolling now · 8 studies all time

What they study most

Breast Cancer, Burkitt's Lymphoma, Carcinoma, Diffuse Large B Cell Lymphoma, Esophageal Adenocarcinoma, Follicular Lymphoma, Gastric Adenocarcinoma, Gastroesophageal Junction Adenocarcinoma, Hodgkin Disease, Lymphoplasmacytic Lymphoma, Mantle Cell Lymphoma, Marginal Zone Lymphoma

Studies at this site

• Tucatinib, Trastuzumab, Ramucirumab, and Paclitaxel Versus Paclitaxel and Ramucirumab in Previously Treated HER2+ Gastroesophageal Cancer — Completed
• A Study of Brentuximab Vedotin With Hodgkin Lymphoma (HL) and CD30-expressing Peripheral T-cell Lymphoma (PTCL) — Completed
• Phase III Study of ABI-007(Albumin-bound Paclitaxel) Plus Gemcitabine Versus Gemcitabine in Metastatic Adenocarcinoma of the Pancreas — Completed
• Phase II Study of PX-12 in Patients With Advanced Pancreatic Cancer — Stopped early
• Imexon for Relapsed Follicular and Aggressive Lymphomas — Completed
• A Study of the HSP90 Inhibitor, STA-9090 in Subjects With Stage IIIB or IV Non-Small Cell Lung Cancer (NSCLC) — Completed
• Whole Brain Radiation Therapy With Oxygen, With or Without RSR13, in Women With Brain Metastases From Breast Cancer — Completed
• A Phase 1-2, XIAP Antisense AEG35156 With Gemcitabine in Patients With Advanced Pancreatic Cancer — Stopped early